Clinical Trials Browser

Completed × Interventional × lanreotide × Clear all

NCT00353496 2025-03-05

CLARINET

Phase 3 Completed

264 enrolled 17 charts

Endocrine Tumors

NCT02795858 2025-02-19

A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors

Phase 2 Completed

43 enrolled 11 charts

Carcinoid Tumor

NCT00774930 2022-10-14

ELECT

Phase 3 Completed

115 enrolled 17 charts

Carcinoid Tumor, Diarrhea, Flushing, Neuroendocrine Tumors, Serotonin Syndrome

NCT00842348 2022-10-12

NET729

Phase 3 Completed

89 enrolled 9 charts

Neuroendocrine Tumors

NCT00216372 2020-11-05

Efficacy and Safety of Lanreotide Microparticles as Palliative Treatment in Peritoneal Carcinomatosis

Phase 3 Completed

Carcinoma, Intestinal Obstruction, Peritoneal Neoplasms

NCT00326469 2020-11-05

Efficacy and Safety of Lanreotide Autogel in Tumour Stabilization of Patients With Progressive Neuroendocrine Tumours

Phase 2 Completed

Neuroendocrine Tumors

NCT02698410 2020-10-01

ATLANT

Phase 2 Completed

40 enrolled 17 charts

Neuroendocrine Tumors

NCT00681187 2019-11-22

SAPHE

Phase 4 Completed

26 enrolled 18 charts

Neuroendocrine Tumour With Carcinoid Symptoms

NCT02351128 2017-10-18

PHRC-Merkel

Phase 2 Completed

Carcinoma, Merkel Cell

NCT00495846 2009-08-17

SS-HCC

Phase 2/3 Completed

Gastrointestinal

Carcinoma, Hepatocellular

NCT00627796 2008-03-03

ATG1line

Phase 4 Completed

Acromegaly, Neoplasms